SAN DIEGO, Feb. 4, 2020 /PRNewswire/ -- Biocept,
Inc. (NASDAQ: BIOC), a leading commercial provider of liquid
biopsy tests designed to provide physicians with clinically
actionable information to improve the outcomes of patients
diagnosed with cancer, announces that President and CEO
Michael W. Nall will present a
corporate overview at the 22nd Annual BIO CEO &
Investor Conference on Monday, February 10,
2020, at 9:00 a.m. Eastern
time (6:00 a.m. Pacific time).
The conference is being held at the New York Marriott Marquis
in New York City.
A live webcast of the conference presentation will be available
on the Company's website at ir.biocept.com. A replay of the
webcast will be available for 90 days.
About BIO CEO & Investor Conference
The BIO CEO and Investor Conference is one of the largest
investor conferences focused on established and emerging publicly
traded and select private biotech companies. The event
features issue-oriented plenary sessions, educational sessions
focused on hot therapeutic areas and key business issues, company
presentations, one-on-one meetings, and networking
opportunities.
About Biocept
Biocept, Inc. is a molecular diagnostics company with
commercialized assays for lung, breast, gastric, colorectal and
prostate cancers, and melanoma. The Company uses its
proprietary liquid biopsy technology to provide physicians with
information for treating and monitoring patients diagnosed with
cancer. The Company's patented Target Selector™ liquid biopsy
technology platform captures and analyzes tumor-associated
molecular markers in both circulating tumor cells (CTCs) and in
plasma (ctDNA). With thousands of tests performed, the
platform has demonstrated the ability to identify cancer mutations
and alterations to inform physicians about a patient's disease and
therapeutic options. For additional information, please visit
www.biocept.com.
Contacts
Investors:
LHA Investor Relations
Jody Cain
Jcain@lhai.com
310-691-7100
Media:
CORE IR
Jules Abraham
julesa@coreir.com
917-885-7378
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biocept-to-present-at-the-22nd-annual-bio-ceo--investor-conference-300998277.html
SOURCE Biocept, Inc.